Global miRNA Market Outlook to 2018
NEW YORK, Dec. 24, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
The recent discovery of miRNA and its wide applicability have sparked off a lot of interest among researchers as well as commercial players. Owing to the same, there are numerous clinical trials being organized all over the world in order to assess the potential of miRNA in diverse fields such as Cancer, Asthma, Heart disorders, Diabetes, Hepatitis etc. The report, "Global miRNA Market Outlook to 2018" provides an in-depth analysis of the various aspects of miRNA at the industry as well as the research front.
The market has been divided into three sections i.e., The Americas, Europe and Asia Pacific. These regions have then been analyzed to draw patterns in terms of research areas and applicability. A brief look at the market suggests that cancer is the most researched topic and regions such as United States, United Kingdom, France, Israel and China are the major players interested in evaluating the role played by miRNA.
Most of the current research is focused on utilizing miRNA for diagnostic purposes such as expression profiling, response evaluation and setting potential biomarkers in diseases. Another application is in the field of therapeutics where miRNA mimics and inhibitors are being applied to control gene translation and consequently its expression.
After an exhaustive study of the industry, RNCOS has laid out the primary market players. These players are working over a vast variety of products such as miRNA extraction and purification kits, and miRNA mimics and inhibitors. There are other players who are solely providing miRNA associated diagnostic services and assessing their therapeutic potential.
Overall, even though the market is in its nascent stage at the moment, it is expanding at an almost exponential rate. With new players entering the market, increase in the number of collaborations and strong support from research institutes, the miRNA market is bound to witness rampant diversification and growth in the coming years.
1. Analyst View
2. Research Methodology
3. miRNA - An Introduction
4. miRNA Techniques
4.1 miRNA Purification
4.2 miRNA Labeling
4.3 miRNA Linear Amplification
4.4 miRNA Microarrays
4.5 miRNA qRT-PCR
4.6 miRNA Inhibition
5. Global miRNA Market Outlook to 2018
5.1 By Geography
5.1.1 The Americas
5.1.3 Asia Pacific (APAC)
6. Ongoing miRNA Research by Disease
6.2 Cardiovascular Diseases
6.3 Metabolic Diseases
7. Key Players
7.1 Mirna Therapeutics, Inc.
7.2 Rosetta Genomics, Ltd.
7.3 InteRNA Technologies B.V.
7.4 Santaris Pharma A/S
7.5 Regulus Therapeutics
7.6 miRagen Therapeutics
7.8 Sigma-Aldrich Corporation
7.9 Thermo Fisher Scientific Inc.
7.10 Agilent Technologies Inc.
7.11 Life Technologies Corporation
7.12 System Biosciences
List of Figures:
Figure 3-1: miRNA Biogenesis
Figure 5-1: Global - miRNA Market (Million US$), 2012-2018
Figure 5-2: Ongoing miRNA Research by Geography (%), 2013
Figure 5-3: The Americas - miRNA Market (Million US$), 2012-2018
Figure 5-4: The Americas - Ongoing miRNA Research by Disease (%), 2013
Figure 5-5: Europe - miRNA Market (Million US$), 2012-2018
Figure 5-6: Europe - Ongoing miRNA Research by Disease (%), 2013
Figure 5-7: Europe - Ongoing miRNA Research by Country (%), 2013
Figure 5-8: APAC - miRNA Market (Million US$), 2012-2018
Figure 5-9: APAC - Ongoing miRNA Research by Disease (%), 2013
Figure 5-10: APAC - Ongoing miRNA Research by Country (%), 2013
Figure 6-1: Ongoing miRNA Research by Disease (%), 2013
Figure 6-2: Cancer - Ongoing miRNA Research (%), 2013
List of Tables:
Table 4-1: miRNA Purification Products by Supplier
Table 4-2: miRNA Labeling Products by Supplier
Table 4-3: miRNA Linear Amplification Products by Supplier
Table 4-4: miRNA Microarray Products by Supplier
Table 4-5: miRNA qRT-PCR Products by Supplier
Table 4-6: miRNA Inhibition Products by Supplier
Table 5-1: The Americas - Ongoing miRNA Research (2013)
Table 5-2: Europe - Ongoing miRNA Research (2013)
Table 5-3: APAC - Ongoing miRNA Research (2013)
Table 6-1: miRNAs associated with Cancer
Table 6-2: miRNA associated with Cardiovascular Diseases
Table 6-3: miRNAs associated with Metabolic Disorders
Table 6-4: miRNAs associated with Hepatitis
Table 7-1: Mirna Therapeutics - miRNA Research Pipeline
Table 7-2: Rosetta Genomics - miRNA based Cancer Tests
Table 7-3: InteRNA - miRNA Research Pipeline
Table 7-4: Santaris Pharma - miRNA Research Pipeline
Table 7-5: Regulus Therapeutics - miRNA Research Pipeline
Table 7-6: miRagen - miRNA Research Pipeline
Table 7-7: Qiagen - miRNA Associated Product Line
Table 7-8: Sigma Aldrich - miRNA Associated Product Line
Table 7-9: Thermo Fisher - miRNA Associated Product Line
Table 7-10: Agilent - miRNA Associated Product Line
Table 7-11: Life Technology - miRNA Associated Product Line
Table 7-12: System Biosciences - miRNA Associated Product Line
Table 7-13: GeneCopoeia - miRNA Associated Product Line
To order this report: Global miRNA Market Outlook to 2018
Contact Clare: email@example.com
Intl: +1 339-368-6001